A detailed history of Tria Gen Wealth Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Tria Gen Wealth Management LLC holds 763 shares of LLY stock, worth $625,919. This represents 0.27% of its overall portfolio holdings.

Number of Shares
763
Previous 772 1.17%
Holding current value
$625,919
Previous $450,000 31.78%
% of portfolio
0.27%
Previous 0.22%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024

SELL
$592.2 - $792.28 $5,329 - $7,130
-9 Reduced 1.17%
763 $593,000
Q4 2023

Jan 22, 2024

SELL
$525.19 - $619.13 $662,789 - $781,342
-1,262 Reduced 62.05%
772 $450,000
Q3 2023

Oct 23, 2023

BUY
$434.7 - $599.3 $579,020 - $798,267
1,332 Added 189.74%
2,034 $1.09 Million
Q2 2023

Aug 08, 2023

BUY
$350.74 - $468.98 $246,219 - $329,223
702 New
702 $329,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $779B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Tria Gen Wealth Management LLC Portfolio

Follow Tria Gen Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tria Gen Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tria Gen Wealth Management LLC with notifications on news.